HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease

Detalhes bibliográficos
Autor(a) principal: Pacheco,Matheus Alves
Data de Publicação: 2022
Outros Autores: Cardoso,Silvia Meyer, Honicky,Michele, Moreno,Yara Maria Franco, Lima,Luiz Rodrigo Augustemak de, Marcos,Camila Souza, Back,Isabela de Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Journal of Cardiovascular Sciences (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472022000600784
Resumo: Abstract Background Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity. Objectives To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease. Methods Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (>45 mg/dL), borderline (40-45 mg/dL) and low (<40 mg/dL). We also assessed the “undesirable” levels, consisting of the sum of “borderline” and “low” values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p<0.05 value was adopted as statistically significant. Results Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR: 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c. Conclusion In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.
id SBC-2_f9ea367f527e1975c6ff3c41ad5e3d29
oai_identifier_str oai:scielo:S2359-56472022000600784
network_acronym_str SBC-2
network_name_str International Journal of Cardiovascular Sciences (Online)
repository_id_str
spelling HDL-Cholesterol in Children and Adolescents with Congenital Heart DiseaseChildAdolescentAtherosclerosisHeart DefectsCongenital/geneticsDyslipidemiaCholesterolHDL-Cholesterol/geneticsRisk FactorsAbstract Background Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity. Objectives To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease. Methods Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (>45 mg/dL), borderline (40-45 mg/dL) and low (<40 mg/dL). We also assessed the “undesirable” levels, consisting of the sum of “borderline” and “low” values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p<0.05 value was adopted as statistically significant. Results Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR: 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c. Conclusion In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.Sociedade Brasileira de Cardiologia2022-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472022000600784International Journal of Cardiovascular Sciences v.35 n.6 2022reponame:International Journal of Cardiovascular Sciences (Online)instname:Sociedade Brasileira de Cardiologia (SBC)instacron:SBC10.36660/ijcs.20210106info:eu-repo/semantics/openAccessPacheco,Matheus AlvesCardoso,Silvia MeyerHonicky,MicheleMoreno,Yara Maria FrancoLima,Luiz Rodrigo Augustemak deMarcos,Camila SouzaBack,Isabela de Carloseng2022-11-25T00:00:00Zoai:scielo:S2359-56472022000600784Revistahttp://publicacoes.cardiol.br/portal/ijcshttps://old.scielo.br/oai/scielo-oai.phptailanerodrigues@cardiol.br||revistaijcs@cardiol.br2359-56472359-4802opendoar:2022-11-25T00:00International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC)false
dc.title.none.fl_str_mv HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
title HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
spellingShingle HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
Pacheco,Matheus Alves
Child
Adolescent
Atherosclerosis
Heart Defects
Congenital/genetics
Dyslipidemia
Cholesterol
HDL-Cholesterol/genetics
Risk Factors
title_short HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
title_full HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
title_fullStr HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
title_full_unstemmed HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
title_sort HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease
author Pacheco,Matheus Alves
author_facet Pacheco,Matheus Alves
Cardoso,Silvia Meyer
Honicky,Michele
Moreno,Yara Maria Franco
Lima,Luiz Rodrigo Augustemak de
Marcos,Camila Souza
Back,Isabela de Carlos
author_role author
author2 Cardoso,Silvia Meyer
Honicky,Michele
Moreno,Yara Maria Franco
Lima,Luiz Rodrigo Augustemak de
Marcos,Camila Souza
Back,Isabela de Carlos
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pacheco,Matheus Alves
Cardoso,Silvia Meyer
Honicky,Michele
Moreno,Yara Maria Franco
Lima,Luiz Rodrigo Augustemak de
Marcos,Camila Souza
Back,Isabela de Carlos
dc.subject.por.fl_str_mv Child
Adolescent
Atherosclerosis
Heart Defects
Congenital/genetics
Dyslipidemia
Cholesterol
HDL-Cholesterol/genetics
Risk Factors
topic Child
Adolescent
Atherosclerosis
Heart Defects
Congenital/genetics
Dyslipidemia
Cholesterol
HDL-Cholesterol/genetics
Risk Factors
description Abstract Background Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity. Objectives To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease. Methods Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (>45 mg/dL), borderline (40-45 mg/dL) and low (<40 mg/dL). We also assessed the “undesirable” levels, consisting of the sum of “borderline” and “low” values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p<0.05 value was adopted as statistically significant. Results Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR: 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c. Conclusion In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472022000600784
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472022000600784
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.36660/ijcs.20210106
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cardiologia
publisher.none.fl_str_mv Sociedade Brasileira de Cardiologia
dc.source.none.fl_str_mv International Journal of Cardiovascular Sciences v.35 n.6 2022
reponame:International Journal of Cardiovascular Sciences (Online)
instname:Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
instname_str Sociedade Brasileira de Cardiologia (SBC)
instacron_str SBC
institution SBC
reponame_str International Journal of Cardiovascular Sciences (Online)
collection International Journal of Cardiovascular Sciences (Online)
repository.name.fl_str_mv International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC)
repository.mail.fl_str_mv tailanerodrigues@cardiol.br||revistaijcs@cardiol.br
_version_ 1754732627971014656